相关实验视频

Updated: Jan 18, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

在中风患者入院时的C-反应蛋白水平 - - 一项比较分析

Alexander Bastian Koldborg¹, Malini Vendela Sagar², Christina Kruuse³

¹Neurovascular Research Unit, Department of Neurology, Copenhagen, University Hospital - Herlev and Gentofte, Herlev, Denmark.

Clinical neurology and neurosurgery

|September 7, 2025

概括

在中风患者中,高C反应蛋白 (CRP) 水平表明住院时间较长. 这种炎症标记可能有助于预测中风的复杂性和患者的结果.

科学领域:

神经学神经学
生物化学生物化学
医院管理局医院管理局

背景情况:

脑卒中的严重程度和结果可能与炎症反应有关.
C-反应蛋白 (CRP) 可能与住院时间 (LOS) 相相关,这表明患者因炎症而增加复杂性.

研究的目的:

调查中风或暂时性缺血性发作 (TIA) 住院的患者中C反应蛋白 (CRP) 水平和住院时间 (LOS) 之间的关联.
确定CRP是否可以作为中风患者医院LOS的预后标志物.

主要方法:

在2019-2020年接受非综合性中风病房治疗的2077名患者进行了回顾性横截面研究.
从电子健康记录中提取的数据,包括CRP水平,诊断 (AIS,ICH,TIA),年龄和并发症.
CRP水平分为正常 (<10毫克/升),中度 (10-40毫克/升) 和高 (>40毫克/升).

主要成果:

与正常CRP水平 (0-10 mg/L) 患者相比,高CRP水平 (>40 mg/L) 的患者的LOS显著更长.
在中度CRP水平 (10-40 mg/L) 和LOS之间没有发现显著的关联.
高龄 (≥65岁) 和脑内出血 (ICH) 与长时间的LOS相关,而TIA和COVID-19封锁期与较短的LOS相关.

结论:

升高的C-反应蛋白 (CRP) 水平显示,在急性中风和TIA患者中,可能成为延长住院时间 (LOS) 的预后指标.
CRP可能有助于识别因炎症过程而可能需要更长时间住院的中风患者.

关键词:

在CRP中使用CRP.逗留时间逗留时间一次性中风,中风.

更多相关视频

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...